Preclinical studies of dendrimer prodrugs. - Wikidata - awgldk - TriplyDB

Preclinical studies of dendrimer prodrugs.

Preclinical studies of dendrimer prodrugs.

http://www.wikidata.org/entity/Q38509638

about

Preclinical studies of dendrimer prodrugs.

http://www.wikidata.org/entity/Q38509638

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Preclinical studies of dendrimer prodrugs.

@en

type

label

Preclinical studies of dendrimer prodrugs.

@en

prefLabel

Preclinical studies of dendrimer prodrugs.

@en

P1433

Q38509638-EEBA08CD-C8ED-4EC6-8C75-FE8DB7CE12DA

P1476

Q38509638-7784F6A2-CEA0-41AE-8F16-11FA3DB215F3

P2093

Q38509638-DD7CA546-9D72-41CF-AFD7-B8190D992E3B

P2860

Q38509638-021DA9CE-9F56-4327-9CE4-3A40D0A6127C

Q38509638-044B7088-88C0-40FD-8B53-0CE29AECE0C3

Q38509638-05FB92A0-B181-42B7-ACE4-47CD5BBA47C0

Q38509638-0A00411F-44E0-4FBD-AFCE-C220D3E9C30B

Q38509638-0AC22D05-5DFF-4C84-A0E7-221723B9722A

Q38509638-0FB1D5EE-1EA9-4595-A700-68F27277816F

Q38509638-1BEA8367-063B-4F15-BBBC-05525569BA55

Q38509638-1FA6E769-6570-4942-B6C9-7F653A1867DE

Q38509638-2399F58A-95C3-441E-A54C-5A68BAEF5602

Q38509638-29C27180-0666-4DA4-B1B4-C2681CB217BF

P304

Q38509638-460023B8-6BBC-4CD7-AA7D-3D589E4410ED

P31

Q38509638-FB12ADD5-6E09-4CB8-A250-4A7A06087B5C

P356

Q38509638-B0CD8ECC-87EA-4487-8502-4C597D580D31

P407

Q38509638-C1C45D94-EA0B-4F89-8FF4-911816B1ED33

P433

Q38509638-8118DC8B-CD5C-4C41-AD69-18F59B1A5F53

P478

Q38509638-2A7A9D3F-C7D2-4C44-9C62-D8C59CA2BFDC

P577

Q38509638-23247EFB-B0C8-4A53-A4E3-0178F1CE3604

P698

Q38509638-AD773C37-9DF9-4C4A-966B-2628E5772E98

P356

17425255.2015.1052404

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Preclinical studies of dendrimer prodrugs.

@en

P2093

Chie Kojima

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo

In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation.

Synthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic Acid conjugate with a hydrolyzable schiff base spacer for treating retinal degeneration.

Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine.

Nanoparticle-based theranostic agents

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Designing dendrimers for biological applications.

P304

1303-1315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2015.1052404

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26028253

http://www.w3.org/2001/XMLSchema#string